PHAR300 Pharmacotherapy I Exam Prep – Real Practice Questions, Answers &
Detailed Rationales (Updated 2026) | Drug Therapy Management,
Pharmacokinetics & Pharmacodynamics, Cardiovascular & Respiratory
Medications, Antibiotics & Antimicrobials, Endocrine & Gastrointestinal
Pharmacotherapy, Adverse Drug Reactions, Patient Safety, Clinical Case Studies &
Medication Therapy Planning
Question 1: A 62-year-old male with hypertension and type 2 diabetes is prescribed
lisinopril. Which mechanism best explains the therapeutic benefit of this
medication in reducing cardiovascular risk?
A. Inhibition of calcium influx in vascular smooth muscle
B. Blockade of angiotensin II at the AT1 receptor
C. Inhibition of angiotensin-converting enzyme, reducing angiotensin II formation
D. Direct vasodilation via nitric oxide enhancement
CORRECT ANSWER: C. Inhibition of angiotensin-converting enzyme, reducing
angiotensin II formation
Rationale: Lisinopril is an ACE inhibitor that blocks the conversion of angiotensin I to
angiotensin II, thereby reducing vasoconstriction, aldosterone secretion, and
sympathetic activation. This mechanism provides renal and cardiovascular protection
in patients with diabetes and hypertension, making option C the most accurate
explanation of its therapeutic benefit.
Question 2: Which of the following antihypertensive agents is MOST likely to cause
a persistent dry cough as an adverse effect?
A. Losartan
B. Amlodipine
C. Enalapril
D. Hydrochlorothiazide
CORRECT ANSWER: C. Enalapril
Rationale: ACE inhibitors like enalapril commonly cause a dry, nonproductive cough
due to accumulation of bradykinin and substance P in the respiratory tract. ARBs (e.g.,
losartan) do not inhibit bradykinin breakdown and are less likely to cause this adverse
effect, making enalapril the correct choice.
Question 3: In the management of acute decompensated heart failure with reduced
ejection fraction, which medication is contraindicated due to risk of worsening
outcomes?
A. Furosemide
B. Metoprolol succinate
C. Verapamil
D. Spironolactone
CORRECT ANSWER: C. Verapamil
,Rationale: Non-dihydropyridine calcium channel blockers like verapamil have negative
inotropic effects and can worsen heart failure in patients with reduced ejection fraction.
Guideline-directed medical therapy for HFrEF includes beta-blockers, ACE
inhibitors/ARBs/ARNIs, MRAs, and SGLT2 inhibitors, but avoids agents with significant
negative inotropy.
Question 4: A patient with chronic stable angina is prescribed sublingual
nitroglycerin for acute symptom relief. What is the primary mechanism by which
nitroglycerin alleviates anginal pain?
A. Beta-1 receptor blockade reducing myocardial oxygen demand
B. Venodilation reducing preload and myocardial oxygen consumption
C. Coronary artery vasodilation increasing oxygen supply exclusively
D. Inhibition of platelet aggregation preventing thrombus formation
CORRECT ANSWER: B. Venodilation reducing preload and myocardial oxygen
consumption
Rationale: Nitroglycerin primarily causes venodilation, which reduces venous return
(preload), thereby decreasing left ventricular end-diastolic volume and wall tension.
This reduces myocardial oxygen demand, which is the principal mechanism for relieving
angina. While some coronary vasodilation occurs, the preload reduction is the
dominant therapeutic effect.
Question 5: Which antiarrhythmic medication is classified as a Class III agent
according to the Vaughan Williams classification?
A. Lidocaine
B. Propranolol
C. Amiodarone
D. Verapamil
CORRECT ANSWER: C. Amiodarone
Rationale: Class III antiarrhythmics primarily block potassium channels, prolonging
repolarization and the action potential duration. Amiodarone is a Class III agent (though
it has multi-class properties). Lidocaine is Class IB, propranolol is Class II, and
verapamil is Class IV.
Question 6: A 58-year-old female with atrial fibrillation and a CHA₂DS₂-VASc score
of 4 requires anticoagulation. Which agent is a direct oral anticoagulant (DOAC)
that directly inhibits factor Xa?
A. Warfarin
B. Dabigatran
C. Apixaban
D. Enoxaparin
CORRECT ANSWER: C. Apixaban
,Rationale: Apixaban is a direct factor Xa inhibitor, classified as a DOAC. Dabigatran
directly inhibits thrombin (factor IIa). Warfarin is a vitamin K antagonist, and enoxaparin
is a low-molecular-weight heparin. For nonvalvular atrial fibrillation, DOACs like
apixaban are preferred over warfarin in most patients due to predictable
pharmacokinetics and fewer drug interactions.
Question 7: Which lipid-lowering agent works primarily by inhibiting HMG-CoA
reductase?
A. Ezetimibe
B. Fenofibrate
C. Atorvastatin
D. Niacin
CORRECT ANSWER: C. Atorvastatin
Rationale: Statins like atorvastatin competitively inhibit HMG-CoA reductase, the rate-
limiting enzyme in cholesterol synthesis, leading to upregulation of hepatic LDL
receptors and reduced circulating LDL-C. Ezetimibe inhibits intestinal cholesterol
absorption, fenofibrate activates PPAR-α, and niacin reduces VLDL secretion.
Question 8: A patient with asthma experiences worsening symptoms despite
regular use of albuterol. Which medication should be added as first-line controller
therapy?
A. Oral prednisone
B. Inhaled corticosteroid
C. Theophylline
D. Montelukast
CORRECT ANSWER: B. Inhaled corticosteroid
Rationale: According to GINA guidelines, inhaled corticosteroids are the most effective
first-line controller therapy for persistent asthma, reducing airway inflammation and
exacerbation risk. Short-acting beta-agonists like albuterol are for rescue only.
Montelukast and theophylline are alternative add-on therapies, not first-line controllers.
Question 9: Which medication used in COPD management is a long-acting
muscarinic antagonist (LAMA)?
A. Salmeterol
B. Tiotropium
C. Fluticasone
D. Roflumilast
CORRECT ANSWER: B. Tiotropium
Rationale: Tiotropium is a LAMA that blocks acetylcholine at M3 receptors in bronchial
smooth muscle, causing bronchodilation. Salmeterol is a LABA, fluticasone is an
, inhaled corticosteroid, and roflumilast is a phosphodiesterase-4 inhibitor used for
severe COPD with chronic bronchitis.
Question 10: A patient with GERD is prescribed omeprazole. What is the primary
mechanism of action of this medication?
A. Histamine H2-receptor antagonism reducing gastric acid secretion
B. Proton pump inhibition blocking final step of acid production
C. Sucralfate coating protecting gastric mucosa
D. Antacid neutralization of existing gastric acid
CORRECT ANSWER: B. Proton pump inhibition blocking final step of acid
production
Rationale: Omeprazole is a proton pump inhibitor that irreversibly inhibits the H+/K+
ATPase enzyme in gastric parietal cells, blocking the final common pathway of acid
secretion. H2-receptor antagonists (e.g., famotidine) work upstream, while sucralfate
and antacids have different mechanisms.
Question 11: Which medication is considered first-line pharmacotherapy for
Helicobacter pylori eradication in a patient without penicillin allergy?
A. Metronidazole alone
B. Clarithromycin, amoxicillin, and a proton pump inhibitor
C. Tetracycline and bismuth subsalicylate
D. Fluoroquinolone monotherapy
CORRECT ANSWER: B. Clarithromycin, amoxicillin, and a proton pump inhibitor
Rationale: Standard first-line triple therapy for H. pylori in regions with low
clarithromycin resistance includes a PPI, clarithromycin, and amoxicillin for 14 days.
Bismuth quadruple therapy is an alternative. Monotherapy or dual therapy is inadequate
due to high resistance and treatment failure rates.
Question 12: A patient with type 2 diabetes is initiated on metformin. Which
adverse effect is MOST commonly associated with this medication?
A. Hypoglycemia
B. Lactic acidosis
C. Gastrointestinal distress
D. Weight gain
CORRECT ANSWER: C. Gastrointestinal distress
Rationale: Metformin commonly causes dose-related GI side effects such as diarrhea,
nausea, and abdominal discomfort, especially during initiation. Hypoglycemia is rare
with metformin monotherapy. Lactic acidosis is a rare but serious risk, primarily in
patients with renal impairment or other contraindications. Weight neutrality or modest
weight loss is typical.
Detailed Rationales (Updated 2026) | Drug Therapy Management,
Pharmacokinetics & Pharmacodynamics, Cardiovascular & Respiratory
Medications, Antibiotics & Antimicrobials, Endocrine & Gastrointestinal
Pharmacotherapy, Adverse Drug Reactions, Patient Safety, Clinical Case Studies &
Medication Therapy Planning
Question 1: A 62-year-old male with hypertension and type 2 diabetes is prescribed
lisinopril. Which mechanism best explains the therapeutic benefit of this
medication in reducing cardiovascular risk?
A. Inhibition of calcium influx in vascular smooth muscle
B. Blockade of angiotensin II at the AT1 receptor
C. Inhibition of angiotensin-converting enzyme, reducing angiotensin II formation
D. Direct vasodilation via nitric oxide enhancement
CORRECT ANSWER: C. Inhibition of angiotensin-converting enzyme, reducing
angiotensin II formation
Rationale: Lisinopril is an ACE inhibitor that blocks the conversion of angiotensin I to
angiotensin II, thereby reducing vasoconstriction, aldosterone secretion, and
sympathetic activation. This mechanism provides renal and cardiovascular protection
in patients with diabetes and hypertension, making option C the most accurate
explanation of its therapeutic benefit.
Question 2: Which of the following antihypertensive agents is MOST likely to cause
a persistent dry cough as an adverse effect?
A. Losartan
B. Amlodipine
C. Enalapril
D. Hydrochlorothiazide
CORRECT ANSWER: C. Enalapril
Rationale: ACE inhibitors like enalapril commonly cause a dry, nonproductive cough
due to accumulation of bradykinin and substance P in the respiratory tract. ARBs (e.g.,
losartan) do not inhibit bradykinin breakdown and are less likely to cause this adverse
effect, making enalapril the correct choice.
Question 3: In the management of acute decompensated heart failure with reduced
ejection fraction, which medication is contraindicated due to risk of worsening
outcomes?
A. Furosemide
B. Metoprolol succinate
C. Verapamil
D. Spironolactone
CORRECT ANSWER: C. Verapamil
,Rationale: Non-dihydropyridine calcium channel blockers like verapamil have negative
inotropic effects and can worsen heart failure in patients with reduced ejection fraction.
Guideline-directed medical therapy for HFrEF includes beta-blockers, ACE
inhibitors/ARBs/ARNIs, MRAs, and SGLT2 inhibitors, but avoids agents with significant
negative inotropy.
Question 4: A patient with chronic stable angina is prescribed sublingual
nitroglycerin for acute symptom relief. What is the primary mechanism by which
nitroglycerin alleviates anginal pain?
A. Beta-1 receptor blockade reducing myocardial oxygen demand
B. Venodilation reducing preload and myocardial oxygen consumption
C. Coronary artery vasodilation increasing oxygen supply exclusively
D. Inhibition of platelet aggregation preventing thrombus formation
CORRECT ANSWER: B. Venodilation reducing preload and myocardial oxygen
consumption
Rationale: Nitroglycerin primarily causes venodilation, which reduces venous return
(preload), thereby decreasing left ventricular end-diastolic volume and wall tension.
This reduces myocardial oxygen demand, which is the principal mechanism for relieving
angina. While some coronary vasodilation occurs, the preload reduction is the
dominant therapeutic effect.
Question 5: Which antiarrhythmic medication is classified as a Class III agent
according to the Vaughan Williams classification?
A. Lidocaine
B. Propranolol
C. Amiodarone
D. Verapamil
CORRECT ANSWER: C. Amiodarone
Rationale: Class III antiarrhythmics primarily block potassium channels, prolonging
repolarization and the action potential duration. Amiodarone is a Class III agent (though
it has multi-class properties). Lidocaine is Class IB, propranolol is Class II, and
verapamil is Class IV.
Question 6: A 58-year-old female with atrial fibrillation and a CHA₂DS₂-VASc score
of 4 requires anticoagulation. Which agent is a direct oral anticoagulant (DOAC)
that directly inhibits factor Xa?
A. Warfarin
B. Dabigatran
C. Apixaban
D. Enoxaparin
CORRECT ANSWER: C. Apixaban
,Rationale: Apixaban is a direct factor Xa inhibitor, classified as a DOAC. Dabigatran
directly inhibits thrombin (factor IIa). Warfarin is a vitamin K antagonist, and enoxaparin
is a low-molecular-weight heparin. For nonvalvular atrial fibrillation, DOACs like
apixaban are preferred over warfarin in most patients due to predictable
pharmacokinetics and fewer drug interactions.
Question 7: Which lipid-lowering agent works primarily by inhibiting HMG-CoA
reductase?
A. Ezetimibe
B. Fenofibrate
C. Atorvastatin
D. Niacin
CORRECT ANSWER: C. Atorvastatin
Rationale: Statins like atorvastatin competitively inhibit HMG-CoA reductase, the rate-
limiting enzyme in cholesterol synthesis, leading to upregulation of hepatic LDL
receptors and reduced circulating LDL-C. Ezetimibe inhibits intestinal cholesterol
absorption, fenofibrate activates PPAR-α, and niacin reduces VLDL secretion.
Question 8: A patient with asthma experiences worsening symptoms despite
regular use of albuterol. Which medication should be added as first-line controller
therapy?
A. Oral prednisone
B. Inhaled corticosteroid
C. Theophylline
D. Montelukast
CORRECT ANSWER: B. Inhaled corticosteroid
Rationale: According to GINA guidelines, inhaled corticosteroids are the most effective
first-line controller therapy for persistent asthma, reducing airway inflammation and
exacerbation risk. Short-acting beta-agonists like albuterol are for rescue only.
Montelukast and theophylline are alternative add-on therapies, not first-line controllers.
Question 9: Which medication used in COPD management is a long-acting
muscarinic antagonist (LAMA)?
A. Salmeterol
B. Tiotropium
C. Fluticasone
D. Roflumilast
CORRECT ANSWER: B. Tiotropium
Rationale: Tiotropium is a LAMA that blocks acetylcholine at M3 receptors in bronchial
smooth muscle, causing bronchodilation. Salmeterol is a LABA, fluticasone is an
, inhaled corticosteroid, and roflumilast is a phosphodiesterase-4 inhibitor used for
severe COPD with chronic bronchitis.
Question 10: A patient with GERD is prescribed omeprazole. What is the primary
mechanism of action of this medication?
A. Histamine H2-receptor antagonism reducing gastric acid secretion
B. Proton pump inhibition blocking final step of acid production
C. Sucralfate coating protecting gastric mucosa
D. Antacid neutralization of existing gastric acid
CORRECT ANSWER: B. Proton pump inhibition blocking final step of acid
production
Rationale: Omeprazole is a proton pump inhibitor that irreversibly inhibits the H+/K+
ATPase enzyme in gastric parietal cells, blocking the final common pathway of acid
secretion. H2-receptor antagonists (e.g., famotidine) work upstream, while sucralfate
and antacids have different mechanisms.
Question 11: Which medication is considered first-line pharmacotherapy for
Helicobacter pylori eradication in a patient without penicillin allergy?
A. Metronidazole alone
B. Clarithromycin, amoxicillin, and a proton pump inhibitor
C. Tetracycline and bismuth subsalicylate
D. Fluoroquinolone monotherapy
CORRECT ANSWER: B. Clarithromycin, amoxicillin, and a proton pump inhibitor
Rationale: Standard first-line triple therapy for H. pylori in regions with low
clarithromycin resistance includes a PPI, clarithromycin, and amoxicillin for 14 days.
Bismuth quadruple therapy is an alternative. Monotherapy or dual therapy is inadequate
due to high resistance and treatment failure rates.
Question 12: A patient with type 2 diabetes is initiated on metformin. Which
adverse effect is MOST commonly associated with this medication?
A. Hypoglycemia
B. Lactic acidosis
C. Gastrointestinal distress
D. Weight gain
CORRECT ANSWER: C. Gastrointestinal distress
Rationale: Metformin commonly causes dose-related GI side effects such as diarrhea,
nausea, and abdominal discomfort, especially during initiation. Hypoglycemia is rare
with metformin monotherapy. Lactic acidosis is a rare but serious risk, primarily in
patients with renal impairment or other contraindications. Weight neutrality or modest
weight loss is typical.
